T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Clinical trial NCT06048718 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06048718
- Sponsor
- MedSIR
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-05
- Primary completion
- 2026-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.